Shares of TTM Technologies surged 6.5% to $215.88 after the circuit-board giant announced all-cash deals to acquire two privately held European manufacturers — its first-ever production footprint on the continent. The move extends a stock that has already delivered a staggering return, and raises a pointed question: are investors paying for proven earnings or for a strategy that has yet to show results?
• Two Deals, One Bet on Europe's Defense and Medical Spending
TTM will buy Swiss Technology Group AG, based in Zurich, and ILFA GmbH, based in Hannover, Germany, in separate all-cash transactions pending regulatory approval.
The Swiss target adds miniaturized circuit-board capabilities for medical devices — think surgical robots, hearing aids, and implantable technology.
ILFA, a 45-year-old German specialist, brings complex board manufacturing along with strategically valuable certifications in areas like component embedding and fluid-channel integration for aerospace, defense, and industrial customers. For shareholders, this plants TTM's flag in two markets — European defense and medtech — where governments are increasing budgets.
• The Financial Firepower Was Already in Place
Just two weeks ago, TTM closed a new $1.0 billion revolving credit facility and a repriced $400 million term loan.
That revolver tripled capacity from $300 million under prior lending lines , signaling management was teeing up deals. The all-cash structure avoids diluting existing shareholders, but investors should watch net debt closely as two acquisitions draw on that freshly expanded balance sheet.
• "Modestly Accretive" Means Don't Expect a Quick Earnings Boost
TTM says the combined deals will be "immediately, albeit modestly, accretive" once closed, excluding purchase-accounting adjustments. Translation: these add a sliver of profit right away, but won't meaningfully move the needle on a company projecting $4.0 billion in 2026 revenue with Q1 net sales already at $846 million. CEO Edwin Roks called them "smaller but meaningful." Detailed financial impact won't be disclosed until the August earnings call.
• A Hot Stock Gets Hotter — Valuation Risk Grows
TTM's stock has returned roughly 457% over the past year, and the company now carries a $21 billion market cap on $3.1 billion in revenue with 23% growth.
InvestingPro analysis flags the stock as overvalued relative to its estimated fair value.
Both deals are expected to close in Q3 2026 , and regulatory approval remains a risk. Investors are paying a premium for the promise of European diversification well before any integration proves successful.